|
Congenital chromosomal disease
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Structural alterations of the c-mos locus in benign pleomorphic adenomas with chromosome abnormalities of 8q12.
|
1677749 |
1991 |
|
Colorectal Neoplasms
|
0.010 |
GeneticVariation
|
group |
BEFREE |
The frequency of the rare 5 kb c-mos allele was significantly higher than that observed in control groups of patients with colorectal neoplasms or lymphoproliferative disorders.
|
1679639 |
1991 |
|
Diarrhea
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
We observed a significant improvement in visual analogic scales at six month for dysmenorrhea (-3.6, p=0.004), dyspareunia (-2.4, p=0.006), diarrhea (-3.0, p=0.006), constipation (-3, p=0.002), dyschezia (-3.2, p=0.003), false urges to defecate (-3.3, p=0.007), posterior pelvic pain (-3.8, p=0.002), and asthenia (-4.3, p=0.002).There was also a significant improvement of the MOS-SF36 with an increase of both Physical Composite Score (+9.3%, p=0.002) and Mental Composite Score (+10.9%, p=0.017) at six months.
|
31788875 |
2019 |
|
Down Syndrome
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Translocation of the MOS gene in a rare t(8;16) associated with acute myeloblastic leukemia and Down syndrome.
|
2522812 |
1989 |
|
Dysmenorrhea
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
We observed a significant improvement in visual analogic scales at six month for dysmenorrhea (-3.6, p=0.004), dyspareunia (-2.4, p=0.006), diarrhea (-3.0, p=0.006), constipation (-3, p=0.002), dyschezia (-3.2, p=0.003), false urges to defecate (-3.3, p=0.007), posterior pelvic pain (-3.8, p=0.002), and asthenia (-4.3, p=0.002).There was also a significant improvement of the MOS-SF36 with an increase of both Physical Composite Score (+9.3%, p=0.002) and Mental Composite Score (+10.9%, p=0.017) at six months.
|
31788875 |
2019 |
|
Eating Disorders
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Participants completed a battery of established self-report measures assessing food addiction, binge-eating and eating-disorder psychopathology (Eating Disorder Examination-Questionnaire; EDE-Q), depressive symptoms (Patient Health Questionnaire-2; PHQ-2), and mental and physical functioning (MOS Short Form Health Survey; SF-12).
|
29870970 |
2018 |
|
Fibromyalgia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The scores in all sleep dimensions of the MOS-sleep were higher in CPP (more disturbances) compared to pain free patients, and differences were observed among the three groups of PCP, with FM most severely affected.
|
28945136 |
2018 |
|
Irritable Bowel Syndrome
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The secondary outcome measures will include the MOS 36-item short-form health survey (SF-36), IBS Quality of Life Questionnaire (IBS-QOL), severity of IBS symptoms (IBS-SSS), and rectal perception.
|
30572430 |
2018 |
|
Myeloid Leukemia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Identification in several human myeloid leukemias or cell lines of a DNA rearrangement next to the c-mos 3'-end.
|
2993032 |
1985 |
|
Liver diseases
|
0.010 |
GeneticVariation
|
group |
BEFREE |
All patients and controls completed one generic HRQL questionnaire (MOS SF-36) and one liver-disease specific instrument (Chronic Liver Disease Questionnaire, CLDQ).
|
17406828 |
2007 |
|
Lymphoproliferative Disorders
|
0.010 |
GeneticVariation
|
group |
BEFREE |
The frequency of the rare 5 kb c-mos allele was significantly higher than that observed in control groups of patients with colorectal neoplasms or lymphoproliferative disorders.
|
1679639 |
1991 |
|
Degenerative polyarthritis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Furthermore, knee function will be measured using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scale, and the quality of life will be measured using the MOS Item Short-form Health Survey (SF-36).
|
29764409 |
2018 |
|
Pheochromocytoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Mutation analysis of the c-mos proto-oncogene and the endothelin-B receptor gene in medullary thyroid carcinoma and phaeochromocytoma.
|
8695346 |
1996 |
|
Depressive Symptoms
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
Participants completed a battery of established self-report measures assessing food addiction, binge-eating and eating-disorder psychopathology (Eating Disorder Examination-Questionnaire; EDE-Q), depressive symptoms (Patient Health Questionnaire-2; PHQ-2), and mental and physical functioning (MOS Short Form Health Survey; SF-12).
|
29870970 |
2018 |
|
Ovarian Teratoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We have analysed the entire coding region of the c-MOS gene in a series of human ovarian teratomas to determine whether there are any cancer-causing alterations.
|
9635841 |
1998 |
|
Ichthyosis Bullosa of Siemens
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The secondary outcome measures will include the MOS 36-item short-form health survey (SF-36), IBS Quality of Life Questionnaire (IBS-QOL), severity of IBS symptoms (IBS-SSS), and rectal perception.
|
30572430 |
2018 |
|
Neoplasms, Intracranial
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Rare Ha-ras and c-mos alleles in patients with intracranial tumors.
|
3352917 |
1988 |
|
Complete Trisomy 21 Syndrome
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Translocation of the MOS gene in a rare t(8;16) associated with acute myeloblastic leukemia and Down syndrome.
|
2522812 |
1989 |
|
Adrenal Gland Pheochromocytoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Mutation analysis of the c-mos proto-oncogene and the endothelin-B receptor gene in medullary thyroid carcinoma and phaeochromocytoma.
|
8695346 |
1996 |
|
Neoplasms
|
0.090 |
Biomarker
|
group |
BEFREE |
Although this result is currently a matter of controversy, further studies must be independently repeated to be conclusive; -- another RFLP was found in c-mos proto-oncogene, which is detected only in patients with breast cancers or other types of tumors.
|
2905174 |
1988 |
|
Neoplasms
|
0.090 |
Biomarker
|
group |
BEFREE |
There was up to 5-fold enrichment of the targeted MSV in the bone marrow of mice bearing early or late stage MDA-MB-231 tumors and of mice with late stage, but not early stage, MCF-7 tumors.
|
24818768 |
2014 |
|
Neoplasms
|
0.090 |
Biomarker
|
group |
BEFREE |
How this process occurs and more importantly, why, has recently become the focus of several research groups, prompting this review in which we discuss two related phenomena that accompany the reversible polyploidy of tumor cells: the induction of meiosis genes such as MOS and the decrease in genomic instability observed during the reversion from polyploidy to para-diploidy.
|
20676137 |
2010 |
|
Neoplasms
|
0.090 |
Biomarker
|
group |
BEFREE |
Female transgenic mice lacking a functional c-mos proto-oncogene develop ovarian teratomas, indicating that c-mos may behave as a tumour-suppressor gene for this type of tumour.
|
9635841 |
1998 |
|
Neoplasms
|
0.090 |
Biomarker
|
group |
BEFREE |
In the present report, we examine, in a series of non-small cell lung carcinomas (NSCLCs), the status of K-ras and c-mos oncoproteins in correlation with the tumor neo-angiogenesis state and the major angiogenic factor, vascular endothelial growth factor (VEGF).
|
11778648 |
2001 |
|
Neoplasms
|
0.090 |
Biomarker
|
group |
BEFREE |
Rhim et al. were first to show that superinfection of Ad12-SV40-infected immortalized human epidermal cells with an RNA tumor virus containing a ras oncogene, such as Ki-MSV, or their treatment with chemical carcinogens, leads to the ability of cells to both grow in anchorage-independent fashion and to form tumors in athymic nude mice.
|
8330279 |
1993 |